RT Journal Article
SR Electronic
A1 Jacobson, Anne
T1 Pioglitazone May Be Effective in Reducing Progression of Atherosclerosis in Patients with Diabetes
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 2
SP 15
OP 15
DO 10.1177/155989770800800212
UL http://mdc.sagepub.com/content/8/2/15.1.abstract
AB Although coronary artery disease accounts for 75% of deaths in patients with diabetes, few studies have compared antidiabetic agents beyond their glucose-lowering efficacy. The prospective, randomized PERISCOPE trialtrial showed that an insulin-sensitizing drug (pioglitazone) may be more effective than a traditional insulin secretagogue (glimepiride) in stopping or reducing the progression of atherosclerosis.